Tiziana Life Sciences to expedite development of TZLS-501 for COVID-19 EP News Bureau Mar 11, 2020 TZLS-501 is a novel fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for treatment of patients…
